	Early Symptomatic Improvement Is Informing Long-Term Quality-of-Life Outcomes with Filgotinib Treatment in Ulcerative Colitis: A Post Hoc Analysis of the SELECTION and SELECTIONLTE Trials. Inflamm Intest Dis Hirai F, Rudolph C, Kaise T, Hibi T. PMID: 42500324 [PubMed]
	Exploratory Risk Patterns of Steroid Dependency in Ulcerative Colitis: A Multicenter Pilot Study Combining Logistic Regression and Self-Organizing Map Analysis. Inflamm Intest Dis Miyatani Y, Takayama T, Okabayashi S, Endo T, Tashiro T, Hojo A, Asonuma K, Sagami S, Hibi T, Nakano M, Kobayashi T. PMID: 42500323 [PubMed]
	Specific carbohydrate diet versus Mediterranean diet in adult patients with mild to moderate ulcerative colitis: a randomized controlled-feeding trial. Front Nutr Chen AS, Nguyen LH, Gray B, Williams K, Gurung J, Canha L, McGoldrick J, Hubbard J, Khalili H. PMID: 42500245 [PubMed]
	The chain mediating roles of stigma and health-promoting lifestyle in the relationship between disability index and posttraumatic growth among patients with inflammatory bowel disease. Front Public Health Wang Y, Chen Y, Gao X, Xun L, Jiang B, Jin X. PMID: 42500003 [PubMed - indexed for MEDLINE]
	Highlights of the 2026 European Crohn's and Colitis Conference: redefining the IBD care continuum. Crohns Colitis 360 Al-Hindawi A, Siegel A, Miranda CJ, Maddineni G, Shehab M. PMID: 42499815 [PubMed]
	Not all weight loss is psychiatric: Diagnostic bias in pediatric Crohn's disease. JPGN Rep Jamrozik KA, Begucci M, Dargenio VN, Bergmann N, Hellberg LC, Schumacher HF, Cristofori F, Francavilla R. PMID: 42499746 [PubMed - as supplied by publisher]
	C-reactive protein/albumin ratio as a potential inflammatory marker for predicting clinical outcomes in patients with moderate to severe ulcerative colitis: A retrospective study. Medicine (Baltimore) Morshed A, Alborzi Avanaki F, Miroliaee A, Azarboo A, Ghaseminejad-Raeini A, Shirinezhad A, Khayatian S, Latifinasab M, Aletaha N, Ebrahimi Daryani N. PMID: 42499090 [PubMed - indexed for MEDLINE]
	The intellectual structure and emerging trends on nanotechnology in inflammatory bowel disease: A bibliometric analysis from 2005 to 2024. Medicine (Baltimore) Liang L, Wang D, Zhang X, Yang H, Zhang X, Li L, Tian G, Yue C, Du W. PMID: 42499024 [PubMed - indexed for MEDLINE]
	Investigating causal associations between inflammatory bowel disease and IgA vasculitis: Univariable and multivariable Mendelian randomization study. Medicine (Baltimore) Yi B, Luo Y, Li H, Nie Y, Zhu S. PMID: 42499022 [PubMed - indexed for MEDLINE]
	Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation. Naunyn Schmiedebergs Arch Pharmacol Fan Z, Zhao L, Ding N, Wang Y, Li D, Zhang S. PMID: 42498802 [PubMed - as supplied by publisher]
	The Vanishing Pouch: Planned Centralisation of Ileal Pouch-Anal Anastomosis for Ulcerative Colitis in Australia-A Regional Consensus Perspective. ANZ J Surg Bhorat N, Cattanach D, Chen M, Cheong J, Chiam HC, Flynn J, Hamilton R, Joy H, Knox R, Lamparelli M, Mackrill D, Naidoo M, Prinsloo P, Ruggiero B, Smith N. PMID: 42498690 [PubMed - as supplied by publisher]
	Ustekinumab for fistulising perianal Crohn's disease: a randomised placebo-controlled trial from the GETAID. Gut Wils P, Nancey S, Messmer E, Bourreille A, Buisson A, Caillo L, Vuitton L, Altwegg R, Hébuterne X, Ernst O, Meunier P, Laurent V, Paul S, Laharie D, Vicaut E, Peyrin-Biroulet L, Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID). PMID: 42498622 [PubMed - as supplied by publisher]
	Fecal incontinence among patients with ulcerative colitis and relation with disease activity, and extent: A cross-sectional study. Arab J Gastroenterol Hanayama M, Furukawa S, Miyake T, Yoshida O, Shiraishi K, Tange K, Hashimoto Y, Suzuki S, Ohashi K, Tomida H, Yamamoto Y, Takeshita E, Ikeda Y, Hiasa Y. PMID: 42498555 [PubMed - as supplied by publisher]
	Targeting cystathionine-Î²-synthase (CBS)-mediated cell stemness and gut microbiome homeostasis: mechanism and clinical study of combined resveratrol-curcumin treatment for ulcerative colitis. Phytomedicine Su S, Ren L, Wang S, Zhang Z, Yang K, Zhou D, Wang M, Xi X, Zhong W. PMID: 42497521 [PubMed - as supplied by publisher]
	"Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials" by Bhandari et al. J Crohns Colitis Rimola J, Fernàndez-Clotet A, Ordás I. PMID: 42497416 [PubMed - in process]
	Pharmacokinetic model selection for infliximab based on inflammatory bowel disease phenotype and severity: Toward model-informed precision dosing. PLoS One Hom, Jovanovi, Markovi, Vezmar Kova, Kne, Kralj , Svorcan P, Vu. PMID: 42497217 [PubMed - indexed for MEDLINE]
	Effects of cuproptosis and its application in inflammatory bowel disease (Review). Int J Mol Med Chen L, Akanyibah FA, Guan J, Pei B, Wang B, Mao F. PMID: 42495776 [PubMed - indexed for MEDLINE]
	Long-Term Outcomes After Stoma Creation in Crohn's Disease: A Retrospective Cohort Study of 422 Patients. Ann Gastroenterol Surg Nagano K, Kuwahara R, Tomoo Y, Kusunoki K, Horio Y, Kimura K, Kataoka K, Ikeda M, Uchino M, Ikeuchi H. PMID: 42495659 [PubMed - as supplied by publisher]
	Mechanistic remodeling and immunoregulatory functions of the B cell-humoral immunity axis in inflammatory bowel disease. Front Immunol Zhang T, Ren Z, Zhang H, Pan Z, Chen M, Bu S, Cheng X, Peng J, Yu Y. PMID: 42495645 [PubMed - indexed for MEDLINE]
	Serum immune profiling suggests overlap between IBD patients with joint complaints and patients with spondyloarthritis. Front Immunol Veltkamp SHC, van Gaalen FA, de Bruin LJE, van Erp SJ, Samsom JN, van der Meulen-de Jong AE, Voorneveld PW. PMID: 42495644 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 58376

Page 1 of 2919



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy